Skip to main content
SpringerLink
Log in

Methods for Testing Pharmacodynamic Variables of Hemophilia and Inhibitor Therapy: Thrombin Generation Assay and Other Tests

  • Conference paper
34th Hemophilia Symposium

  • 578 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Turecek PL, Varadi K, Gritsch H, Auer W, Pichler L, Eder G, Schwarz HP. Factor Xa and Prothrombin. Mechanism of action of FEIBA. Vox Sang 1999; 77(Suppl 1):72–9.

    PubMed  CAS  Google Scholar 

  2. Ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest 1993; 92:1207–12.

    Article  PubMed  CAS  Google Scholar 

  3. Hoffman M., Monroe D.M. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Seminars in Hematology 2001; 38:6–9.

    Article  PubMed  CAS  Google Scholar 

  4. Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Hedner U, Roberts HR. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation. Blood Coagul Fibrinolysis 1998 Suppl 1; 9:S21–S25.

    Google Scholar 

  5. Turecek PL, Váradi K, Schwarz HP. Prothrombin-factor Xa Complex-The active principle behind APCCs, a review and summary of current data. J Thromb Thrombolysis (in press)

    Google Scholar 

  6. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948; 26:577–583.

    PubMed  CAS  Google Scholar 

  7. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551–558.

    Article  PubMed  CAS  Google Scholar 

  8. Macfarlane, RG, Biggs, R. A thrombin genenration test: the application in haemophilia and thrombocytopenia. J Clin Pathol 1953; 6: 3–8.

    PubMed  CAS  Google Scholar 

  9. Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56:9–17.

    PubMed  CAS  Google Scholar 

  10. Schwarz HP, Rengs H, Elsinger F. An assay for the bioavailability of FEIBA. Abstract at the KYOTO Satellite Symposia of the XIIth ISTH-Congress, Kyoto, 27.-28.08.89.

    Google Scholar 

  11. Gill C, Schwarz HP, Wentz MA, Montgomery RR. Platelet prothrombinase activity may predict successful activated prothrombin complex concentrate (FEIBA) Treatment. Blood 1990; 76(Suppl.1):399a.

    Google Scholar 

  12. Sultan Y, Loyer F. In vitro evaluation of factor VIII-bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets. J Lab Clin Med 1993; 121:444–452.

    PubMed  CAS  Google Scholar 

  13. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4–15.

    PubMed  CAS  Google Scholar 

  14. Turecek PL, Váradi K, Keil B, Negrier C, Berntorp E, Astermark J, Bordet J-C, Morfini M, Linari S, Schwarz HP. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 2003; 33:16–22.

    Article  PubMed  CAS  Google Scholar 

  15. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74:134–38.

    PubMed  CAS  Google Scholar 

  16. Yoshioka A, Nishio K, Shima M. Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII. Haemostasis 1996; 26:139–142.

    PubMed  CAS  Google Scholar 

  17. Shima M. Understanding the hemostatic effects of recombinant factor VIIa by clot waveform analysis. Semin Hematol 2004; 41:125–131.

    Article  PubMed  CAS  Google Scholar 

  18. Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost 2002; 87:436–41.

    PubMed  CAS  Google Scholar 

  19. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551–558.

    Article  PubMed  CAS  Google Scholar 

  20. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost. 2004; 2:102–110.

    Article  PubMed  CAS  Google Scholar 

  21. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88:576–82.

    PubMed  CAS  Google Scholar 

  22. Varadi K, Negrier C, Berntorp E, Astermark J, Bordet J-C, Morfini M, Linari S, Schwarz HP, Turecek PL. Monitoring the biovailability of FEIBA with a thrombin generation assay. J Thromb Haemost 2003; 1:2374–2380.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K. Váradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. P. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. L. Turecek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    I. Scharrer

  2. Dept. of Hemostaseology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    W. Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this paper

Cite this paper

Váradi, K., Schwarz, H.P., Turecek, P.L. (2005). Methods for Testing Pharmacodynamic Variables of Hemophilia and Inhibitor Therapy: Thrombin Generation Assay and Other Tests. In: Scharrer, I., Schramm, W. (eds) 34th Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27022-1_40

Download citation

  • DOI: https://doi.org/10.1007/3-540-27022-1_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22886-8

  • Online ISBN: 978-3-540-27022-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation